1 / 3

PTCA Coronary Drug Eluting Balloons (DEB) Market Analysis 2015

“The Report PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Review 2015 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz”

Télécharger la présentation

PTCA Coronary Drug Eluting Balloons (DEB) Market Analysis 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PTCA Coronary Drug Eluting Balloons (DEB) Market Size, Industry Analysis, Shares, Trends and Forecast 2015 “The Report PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Review 2015 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz” Summary GlobalData's Medical Devices sector report, PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Review, 2015" provides an overview of PTCA Coronary Drug Eluting Balloon (DEB) products currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key PTCA Coronary Drug Eluting Balloon (DEB) pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. View Full Report at http://www.marketresearchreports.biz/analysis/308831 Scope - Extensive coverage of the PTCA Coronary Drug Eluting Balloon (DEB) products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of PTCA Coronary Drug Eluting Balloon (DEB) products and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry

  2. Download sample Copy of This Report at http://www.marketresearchreports.biz/sample/sample/308831 Reasons to buy The report enables you to - - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter- strategies to gain competitive advantage - Identify and understand important and diverse types of PTCA Coronary Drug Eluting Balloon (DEB) products under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the products current stage of development, territory and estimated launch date Table of Contents 1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 3 1.2 List of Figures 4 2 Introduction 5 2.1 PTCA Coronary Drug Eluting Balloons (DEB) Overview 5 3 Products under Development 6 3.1 PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development 6 3.2 PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Territory 7 3.3 PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Regulatory Path 8 3.4 PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Estimated Approval Date 9 3.5 PTCA Coronary Drug Eluting Balloons (DEB) - Ongoing Clinical Trials 10 4 PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products under Development by Companies 11 4.1 PTCA Coronary Drug Eluting Balloons (DEB) Companies - Pipeline Products by Stage of Development 11 4.2 PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Products by Stage of Development 12 5 PTCA Coronary Drug Eluting Balloons (DEB) Companies and Product Overview 13 5.1 Acrostak (Schweiz) AG Company Overview 13 5.1.1 Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 13 5.2 B. Braun Melsungen AG Company Overview 15 5.2.1 B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview 15 5.3 Concept Medical Inc Company Overview 24 5.3.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 24 5.4 Eurocor GmbH Company Overview 28 5.4.1 Eurocor GmbH Pipeline Products & Ongoing Clinical Trials Overview 28 5.5 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 30 5.5.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30 5.6 Maxcor Inc. Company Overview 31 5.6.1 Maxcor Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 5.7 Micell Technologies, Inc. Company Overview 32 5.7.1 Micell Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32

  3. 5.8 QualiMed Innovative Medizinprodukte GmbH Company Overview 34 5.8.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 34 5.9 The Spectranetics Corporation Company Overview 36 5.9.1 The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 36 5.10 Vascular Nanotransfer Technologies Company Overview 38 5.10.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview 38 6 PTCA Coronary Drug Eluting Balloons (DEB)- Recent Developments 40 7 Appendix 46 7.1 Methodology 46 7.2 About GlobalData 48 7.3 Contact Us 48 7.4 Disclaimer 48 To View The Top Article Of Comapny: http://www.marketresearchreports.biz/articles About Us MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. Contact Us Mr. Nachiket Office: State Tower 90 Sate Street, Suite 700 Albany, NY 12207 United States Tel: +1-518-621-2074 Website: http://www.marketresearchreports.biz/ E: sales@marketresearchreports.biz

More Related